Literature DB >> 34661158

Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic Leukemia.

Heidi Segers1,2, Jan Cools3,4.   

Abstract

Cytogenetics supported by additional molecular analyses and minimal residual disease detection have been successfully combined to improve the outcome of childhood acute lymphoblastic leukemia (ALL). Results from the St. Jude Total Therapy Study 16 demonstrate that some of the recently identified ALL subtypes can further guide risk stratification. See related article by Jeha et al., p. 326. ©2021 American Association for Cancer Research.

Entities:  

Year:  2021        PMID： 34661158      PMCID： PMC8504769          DOI： 10.1158/2643-3230.BCD-21-0068

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN： 2643-3230


  10 in total

Review 1.  A 50-year journey to cure childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

2.  Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.

Authors:  Jian-Feng Li; Yu-Ting Dai; Henrik Lilljebjörn; Shu-Hong Shen; Bo-Wen Cui; Ling Bai; Yuan-Fang Liu; Mao-Xiang Qian; Yasuo Kubota; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Linda Olsson; Ah Moy Tan; Hany Ariffin; Jing Chen; Junko Takita; Takahiko Yasuda; Hiroyuki Mano; Bertil Johansson; Jun J Yang; Allen Eng-Juh Yeoh; Fumihiko Hayakawa; Zhu Chen; Ching-Hon Pui; Thoas Fioretos; Sai-Juan Chen; Jin-Yan Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-28       Impact factor: 11.205

3.  Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.

Authors:  Stephanie B Dixon; Yan Chen; Yutaka Yasui; Ching-Hon Pui; Stephen P Hunger; Lewis B Silverman; Kirsten K Ness; Daniel M Green; Rebecca M Howell; Wendy M Leisenring; Nina S Kadan-Lottick; Kevin R Krull; Kevin C Oeffinger; Joseph P Neglia; Ann C Mertens; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong; Paul C Nathan
Journal:  J Clin Oncol       Date:  2020-07-24       Impact factor: 44.544

4.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

5.  Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

Authors:  H Cavé; J van der Werff ten Bosch; S Suciu; C Guidal; C Waterkeyn; J Otten; M Bakkus; K Thielemans; B Grandchamp; E Vilmer
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

6.  Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Authors:  Ajay Vora; Nick Goulden; Rachel Wade; Chris Mitchell; Jeremy Hancock; Rachael Hough; Clare Rowntree; Sue Richards
Journal:  Lancet Oncol       Date:  2013-02-07       Impact factor: 41.316

7.  Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

Authors:  Rob Pieters; Hester de Groot-Kruseman; Vincent Van der Velden; Marta Fiocco; Henk van den Berg; Evelien de Bont; R Maarten Egeler; Peter Hoogerbrugge; Gertjan Kaspers; Ellen Van der Schoot; Valerie De Haas; Jacques Van Dongen
Journal:  J Clin Oncol       Date:  2016-06-06       Impact factor: 44.544

8.  Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.

Authors:  Sima Jeha; Deqing Pei; John Choi; Cheng Cheng; John T Sandlund; Elaine Coustan-Smith; Dario Campana; Hiroto Inaba; Jeffrey E Rubnitz; Raul C Ribeiro; Tanja A Gruber; Susana C Raimondi; Raja B Khan; Jun J Yang; Charles G Mullighan; James R Downing; William E Evans; Mary V Relling; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2019-10-28       Impact factor: 44.544

9.  Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Authors:  Sima Jeha; John Choi; Kathryn G Roberts; Deqing Pei; Elaine Coustan-Smith; Hiroto Inaba; Jeffrey E Rubnitz; Raul C Ribeiro; Tanja A Gruber; Susana C Raimondi; Seth E Karol; Chunxu Qu; Samuel W Brady; Zhaohui Gu; Jun J Yang; Cheng Cheng; James R Downing; Williams E Evans; Mary V Relling; Dario Campana; Charles G Mullighan; Ching-Hon Pui
Journal:  Blood Cancer Discov       Date:  2021-07

10.  Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

Authors:  Henrik Lilljebjörn; Rasmus Henningsson; Axel Hyrenius-Wittsten; Linda Olsson; Christina Orsmark-Pietras; Sofia von Palffy; Maria Askmyr; Marianne Rissler; Martin Schrappe; Gunnar Cario; Anders Castor; Cornelis J H Pronk; Mikael Behrendtz; Felix Mitelman; Bertil Johansson; Kajsa Paulsson; Anna K Andersson; Magnus Fontes; Thoas Fioretos
Journal:  Nat Commun       Date:  2016-06-06       Impact factor: 14.919
  10 in total
  1 in total

Review 1.  Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.

Authors:  Yasen Maimaitiyiming; Linyan Ye; Tao Yang; Wenjuan Yu; Hua Naranmandura
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.